On average, there were 4 IPO per month, and nearly 90 % of the companies had VC/PE support. The original investment period of 8-10 years was reduced to about 3-5 years. Total funds raised reached over 200 billion yuan.
China Bio news release, November 30, 2017
In 2017, over 40 pharmaceutical ventures went public in China